CLYMClimb Bio Inc
$10.86+558% 1Y
$10.86
$1.6452 weeks$17.83
Is it safe?
Watch
2 to watch, 4 without dataCaution warranted: heavy debt (CCC) and big price swings.
Credit gradeCCCderived · Jun 30, 2026
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Drawdown risk89% volderived · Oct 8, 2026
Large price swings, high volatility. Worst drawdown -96% · now 39% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can CLYM take a bad year?
The deepest fall in CLYM's price history on file is −96%; it is 39% below its high today.
−96%
Worst drawdown on file · −39% today
- Annualised volatility
- 89%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $183M
- EBITDA, trailing twelve months
- −$65M
- Operating profit, trailing twelve months
- −$65M
- Annualised volatilitytwo years of daily moves
- 89%
- Worst drawdown on file
- −96%
- Below its 52-week high
- 39%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.